Submitted by Anonymous (not verified) on 17 September 2026 - 16:22
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 4, Status: Authorised